An updated review of SARS-CoV-2 vaccines and the importance of effective vaccination programs in pandemic times

C García-Montero, O Fraile-Martínez, C Bravo… - Vaccines, 2021 - mdpi.com
Since the worldwide COVID-19 pandemic was declared a year ago, the search for vaccines
has become the top priority in order to restore normalcy after 2.5 million deaths worldwide …

The impact of COVID-19 on liver injury

RM Dawood, GM Salum, M Abd El-Meguid - The American Journal of the …, 2022 - Elsevier
The current coronavirus disease outbreak of 2019 (COVID-19) has led to a global pandemic.
The principal cause of mortality in COVID-19 is represented lung injury with the …

Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response

Y Renaudineau, F Abravanel, J Izopet, C Bost… - Clinical …, 2022 - Elsevier
We explored the performance of a whole blood interferon gamma release assay (IGRA)
based on the stimulation of SARS-Cov2-specific T cells by purified recombinant proteins …

Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic

X Li, L Zhang, S Chen, W Ji, C Li, L Ren - Infection, Genetics and Evolution, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) infection has caused
a global pandemic in the past year, which poses continuing threat to human beings. To date …

Genomic landscape of alpha-variant of SARS-CoV-2 circulated in Pakistan

N Fiaz, I Zahoor, S Saima, A Basheer - Plos one, 2022 - journals.plos.org
In this study, we investigated the genomic variability of alpha-VOC of SARS-CoV-2 in
Pakistan, in context of the global population of this variant. A set of 461 whole-genome …

Analysis of IgG, IgA and IgM antibodies against SARS‐CoV‐2 spike protein S1 in convalescent and vaccinated patients with the Pfizer‐BioNTech and CanSinoBio …

EA Melgoza‐González… - Transboundary and …, 2022 - Wiley Online Library
The SARS‐CoV‐2 virus was detected for the first time in December 2019 in Wuhan, China.
Currently, this virus has spread around the world, and new variants have emerged. This new …

In silico analysis of a candidate multi-epitope peptide vaccine against human brucellosis

Z Yazdani, A Rafiei, M Ghoreyshi… - Molecular …, 2024 - Springer
Brucellosis is one of the neglected endemic zoonoses in the world. Vaccination appears to
be a promising health strategy to prevent it. This study used advanced computational …

Conserved pattern and potential role of recurrent deletions in SARS-CoV-2 evolution

S Weng, H Zhou, C Ji, L Li, N Han, R Yang… - Microbiology …, 2022 - Am Soc Microbiol
ABSTRACT SARS-CoV-2 continues adapting to human hosts during the current worldwide
pandemic since 2019. This virus evolves through multiple means, such as single nucleotide …

Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein

A Wang, Y Tian, H Liu, P Ding, Y Chen… - Emerging Microbes & …, 2022 - Taylor & Francis
Spike (S) glycoprotein is the most significant structural protein of SARS-CoV-2 and a key
target for neutralizing antibodies. In light of the on-going SARS-CoV-2 pandemic …

Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul

BC Piccoli, TR y Castro, LF Tessele, BC Casarin… - Scientific Reports, 2024 - nature.com
The COVID-19 pandemic has been marked by novel viral variants, posing challenges to
global public health. Recombination, a viral evolution mechanism, is implicated in SARS …